Daré Bioscience, Inc.

As momentum around menopause accelerates, we are looking to participating in the Redefining the ROI for Menopause panel at #JPM2026. If you're attending, let's connect!

On Saturday, January 10, CEO Sabrina Johnson will join an panel of leaders at the Longwood Conference to explore how we can better translate scientific breakthroughs into equitable, real-world access for patients. If you’ll be in town for #JPM2026, let’s connect!

We’ve had a big week! From trusted national outlets to leading voices in health, the coverage this past week reflects what we’ve believed all along: women deserve evidence-based solutions designed for their bodies.

We’re proud to see this conversation gaining momentum and grateful to @thisisflowspace for helping elevate the dialogue around women’s pleasure, physiology, and the importance of research-driven solutions.

Thanks to @OprahDaily for helping bring evidence-based women’s health innovations into the spotlight!

The @newyorkpost just highlighted DARE to PLAY™ Sildenafil Cream, a first-of-its-kind prescription cream designed to enhance blood flow to female genital tissue! nypost.com/2025/12/10/hea…

We're thrilled to announce that providers in select states can now begin prescribing DARE to PLAY™ Sildenafil Cream, a proprietary topical arousal cream specifically for women to enhance genital blood flow & arousal response: ir.darebioscience.com/news-releases/…

Most people picture a pharmacist hand-mixing a custom medication when they hear “compounding.” But it’s much bigger than that. Here’s why it matters for your medicine.

Sexual response in women isn’t strictly linear - and it’s not as complex as it’s sometimes made out to be. Dr. Sheryl Kingsberg unpacks the science. You can also catch the full webinar here: youtube.com/watch?v=8dI1cG…

We're pleased to announce an add'l ~$3.6M in grant funding under an existing grant agreement with the Gates Foundation. This funding supports our preclinical efforts to design and develop a novel non-hormonal intravaginal contraceptive aimed at addressing unmet needs in LMIC.

We’re proud to support @DareBioscience, a purpose-driven biotech company pushing women’s health forward with science that's 100% for her. Chrysalis provides flexible GMP Cleanroom Hosting so their team can stay focused on advancing solutions for women at every stage of life.

Women’s sexual health is evolving, and clinicians need the tools to keep pace. That’s why Daré Bioscience is proud to be a Silver Sponsor of the ISSWSH Fall Course. We can’t wait to connect, share insights, and help empower the next generation of leaders in women’s sexual health.

A historic day for women’s health: @HHSGov and @US_FDA are removing outdated “black box” warnings from menopause hormone therapy. A long-overdue move to restore science, trust, and choice in women’s care!

Our CEO will be speaking at @CNSSummit 2025 next week on the panel “Powering Progress in Women’s Health: Science, Strategy, and Social Impact.” This discussion brings together three leaders advancing innovation in women’s health therapeutics. Join us in Boston on Nov 3rd!

Our CEO @SabrinaDareCEO is a finalist at this year's Women In Innovation Awards! If you’ll be in NYC on Oct 24th, click the link below and use code WINSQUAD at checkout for 15% off tickets to help celebrate these incredible women! eventbrite.com/e/women-in-inn…

This week, our CEO @SabrinaDareCEO will be attending the #IEF2025 in Berlin sponsored by the Gates Foundation + German Health Alliance to spotlight women's health research on a global stage, build powerful partnerships, and turn priorities into real progress.

October is Breast Cancer Awareness Month—today on IG, we’re sharing resources and information about the ongoing journey of survivorship. Follow us @darebioscience

Our VP of Alliance & BD, Nick Pacelli will be attending The MedTech Conf from Oct 5-8. We'll be highlighting DARE-IDDS, our groundbreaking drug delivery platform designed to address significant unmet needs in women’s health & beyond. Attending #MedTechCon? Let’s connect!

With the DARE to PLAY™ launch on the horizon, the Daré team will be out in full force this conference season & exhibiting at four leading health/women’s health conferences. Stop by to learn more about our mission & pipeline. Let’s explore how we can accelerate change together.

Each year, preeclampsia claims the lives of ~76k mothers & 500k babies worldwide. We're thrilled to provide strategic mentorship & technical guidance to the Grand Challenges grantee organizations working in this important space. lnkd.in/g2ShyqZA